Meiji Yasuda Life Insurance CO Exact Sciences Corp Transaction History
Meiji Yasuda Life Insurance CO
- $4.99 Billion
- Q1 2025
A detailed history of Meiji Yasuda Life Insurance CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Meiji Yasuda Life Insurance CO holds 6,707 shares of EXAS stock, worth $343,197. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,707
Previous 6,972
3.8%
Holding current value
$343,197
Previous $391,000
25.83%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$913 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$903 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$640 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$617 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$338 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.06B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...